Synopsis
Synopsis
0
USDMF
 
																							0
CEP/COS
 
																							0
JDMF
 
																							0
EU WC
 
																							0
KDMF
 
																							0
NDC API
 
																							0
VMF
 
																							0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
 
																							0
FDA Orange Book
 
																							0
Europe
 
																							0
Canada
 
																							0
Australia
 
																							0
South Africa
 
																							0
Listed Dossiers
 
																							
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid 
NA
Annual Reports 
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Djt1116pg
1. 2035989-50-3
2. Olorigliflozin
3. Olorigliflozin [inn]
4. 6fp3nst6zq
5. Chembl5314927
6. Schembl18195012
7. (1r,2s,3s,4r,5s)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-((r)-1-hydroxyethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
8. 1,6-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-c-[(1r)-1-hydroxyethyl]-beta-l-idopyranose
9. Beta-l-idopyranose, 1,6-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-c-[(1r)-1-hydroxyethyl]-
| Molecular Weight | 450.9 g/mol | 
|---|---|
| Molecular Formula | C23H27ClO7 | 
| XLogP3 | 2.1 | 
| Hydrogen Bond Donor Count | 4 | 
| Hydrogen Bond Acceptor Count | 7 | 
| Rotatable Bond Count | 6 | 
| Exact Mass | Da | 
| Monoisotopic Mass | Da | 
| Topological Polar Surface Area | 109 | 
| Heavy Atom Count | 31 | 
| Formal Charge | 0 | 
| Complexity | 615 | 
| Isotope Atom Count | 0 | 
| Defined Atom Stereocenter Count | 6 | 
| Undefined Atom Stereocenter Count | 0 | 
| Defined Bond Stereocenter Count | 0 | 
| Undefined Bond Stereocenter Count | 0 | 
| Covalently Bonded Unit Count | 1 | 
ABOUT THIS PAGE
